Tevas Austedo flunks in latestage paediatric Tourette study

Teva’s Austedo flunks in late-stage paediatric Tourette study

05:54 EST 21 Feb 2020 | PharmaTimes

Compared to placebo, the drug didn’t achieve significant reduction in motor and phonic tics.

Original Article: Teva’s Austedo flunks in late-stage paediatric Tourette study

More From BioPortfolio on "Teva’s Austedo flunks in late-stage paediatric Tourette study"